CD19 and ovarian cancer: In regimen one, transfer of C4-27z and C4opt-27z RNA CAR T cells by i.p. administration significantly attenuated the progression of disseminated human ovarian cancer which grew rapidly in saline- and CD19-27z CAR-treated mice (Figures 5A–5B, two-way ANOVA, p < .001, D28).